An in vivo base editing approach targeting the PRNP gene led to a 52% increase in the lifespan of mouse models inoculated with the most common sporadic and genetic types of human pathogenic prion ...

P-Cure, a global leader in precision oncology, proudly announces that Proton ARC therapy will become a routine option for patient treatments at Hadassah Medical Center as part of a Ministry of ...

A pioneering new treatment promises to tackle a wider range of cancers, with fewer side-effects than conventional ...

Mevion Medical Systems, the leader in compact proton therapy solutions, proudly announces the delivery of its first MEVION ...

Alaya.bio, a biotechnology company developing a scalable polymeric delivery platform to precisely target and reprogram cells in situ, is pleased to announce an expanded collaboration with Michel ...

CHESTER TWP. - If not for the balloons and sign pointing to the entrance, it would have been easy to miss the driveway for ...

Hadron therapy is a state-of-the-art radiotherapy technique that uses proton or ion beams to target tumoral cells, while ...

Proton Power Systems PLC (PPS) (ISIN: GB00BP83GZ24)股票专题，提供今日Proton Power Systems PLC(PPS) (ISIN: GB00BP83GZ24)股票最新股价查询，实时市场行情，走势图表，及Proton Power Systems PLC(PPS) (ISIN: ...

The state’s Office of Health Strategy has agreed with Danbury Proton, allowing the organization to open a $72 million proton ...

A state oversight agency approved a longstanding application by a physicians’ group to open an $80 million cancer center on the city’s west side that will use novel proton therapy to precisely target ...